In this issue, Wang et al. provide evidence of the pre-clinical as well as the clinical utility of in vitro-generated directly reprogrammed human hepatocytes in bioartificial liver. This approach will help offer patients a more curative surgical therapy for liver cancer and improve survival rates.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.stem.2023.04.008 | DOI Listing |
Publication Analysis
Top Keywords
bioartificial liver
8
liver reprogrammed
4
reprogrammed hepatocytes
4
hepatocytes ready
4
ready prime
4
prime time
4
time issue
4
issue wang
4
wang et al
4
et al provide
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!